# Tianjin Jinjin Pharmaceutical Co. Ltd. – FDA Inspection, Mar 29, 2024

Source: https://www.keypedia.com/records/fda_inspections/tianjin-jinjin-pharmaceutical-co-ltd/5bd16620-3d77-4db2-8032-57e6f789f62f
Source feed: FDA_Inspections

> FDA inspection 1235608 of Tianjin Jinjin Pharmaceutical Co. Ltd., March 29, 2024. Classification: Voluntary Action Indicated (VAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1235608
- Company Name: Tianjin Jinjin Pharmaceutical Co. Ltd.
- Inspection Date: 2024-03-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 990272 - 2016-09-09
- FDA Inspection 734344 - 2011-06-17

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/brandy-n-lepage/41e679e3-cc2a-4361-bf89-26acbd7deaf8)
- [FDA Associated Person](https://www.keypedia.com/people/karen-a-briggs/3e77d364-25ea-48c7-87f4-36f3e170bfb5)

Company: https://www.keypedia.com/companies/tianjin-jinjin-pharmaceutical-co-ltd/53d9554b-4bbf-4e1a-a625-83cd0aceafba

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c